Eptifibatide

Product Name

Eptifibatide;

Sequence

Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH₂

_{[3-carbamoyl-11-{4-[(diaminomethylidene)amino]butyl}-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid; [(1S,4R,12S,18S,21S)-12-(4-carbamimidamidobutyl)-4-carbamoyl-21-(1H-indol-3-ylmethyl)-2,10,13,16,19,22-hexaoxo-6,7-dithia-3,11,14,17,20,26-hexaazabicyclo[21.2.1]hexacos-18-yl]acetic acid; MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2; INTEGRELIN; N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide; [(3R,11S,17S,20S,25aS)-11-(4-carbamimidamidobutyl)-3-carbamoyl-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid}

Cas No.

148031-34-9

Molecular Formula

C₃₅H₄₉N₁₁O₉S₂

Molecular Weight

832.4

Appearance

White slightly yellwish powder

Specific Rotation[20/D]

-75.0～-95.0°（C=1，1%HAc）

Amino Acids composition

± 10%

Peptide Purity (By HPLC)

≥98% by area integration

Related Substance (By HPLC)

Total Impurities (%)≤2.0% Largest Single Impurity (%)≤ 1.0%

Water Content (Karl Fischer)

≤8.0%

Peptide Content(N determination)

≥80%

Acetate Content

≤15%

IR spectrum

in accordance